US Patent Issued to SUZHONG PHARMACEUTICAL GROUP, JIANGSU SUZHONG PHARMACEUTICAL RESEARCH INSTITUTE on June 17 for "Use of Abelmoschi corolla extract in preparation of drug for treating fibrosis" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,769, issued on June 17, was assigned to SUZHONG PHARMACEUTICAL GROUP Co. LTD. (Taizhou, China) and JIANGSU SUZHONG PHARMACEUTICAL RESEARCH INSTITUTE Co. LTD. (Nanjing, China).

"Use of Abelmoschi corolla extract in preparation of drug for treating fibrosis" was invented by Haitao Tang (Taizhou, China), Zhengyu Cao (Nanjing, China), Boyang Yu (Nanjing, China), Chengzhi Chai (Nanjing, China), Haitao Ge (Taizhou, China) and Zhengjun Wang (Taizhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is the use of an Abelmoschi corolla extract in the preparation of a drug for treating fibrosis, wherein the extract contains at least 15% of gossyp...